Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

4.3K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.3K
Epigenetic Regulation01:46

Epigenetic Regulation

34.6K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.6K
Epigenetic Regulation01:46

Epigenetic Regulation

26.8K
26.8K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

4.5K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.5K
Hematopoiesis01:21

Hematopoiesis

10.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
10.2K
Lineage Commitment01:21

Lineage Commitment

4.6K
Commitment is the  process whereby stem cells:
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Australia's erosion of peer review.

Science (New York, N.Y.)·2026
Same author

Gut health is associated with clonal haematopoiesis in older adults with and without HIV: the ARCHIVE longitudinal cohort study.

Gut·2026
Same author

Blinatumomab in de novo AYA ALL-Results of the Australasian Leukaemia and Lymphoma Group ALL09 "SUBLIME" study.

HemaSphere·2026
Same author

Antigen reactivity defines tissue-resident memory and exhausted T cells in tumors.

Nature immunology·2025
Same author

Histologic Transformation in Cancer: The Path for Clinical Translation.

Cancer discovery·2025
Same author

Antigen reactivity defines tissue-resident memory and exhausted T cells in tumours.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Apr 20, 2026

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

13.4K

Epigenetics in the hematologic malignancies.

Chun Yew Fong1, Jessica Morison2, Mark A Dawson3

  • 1Cancer Epigenetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.

Haematologica
|December 5, 2014
PubMed
Summary

Epigenetic regulators are key in blood cancers. Understanding their abnormal roles in myeloid malignancies is crucial for developing targeted epigenetic therapies.

More Related Videos

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

2.1K
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

5.2K

Related Experiment Videos

Last Updated: Apr 20, 2026

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

13.4K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

2.1K
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

5.2K

Area of Science:

  • Genomics
  • Epigenetics
  • Oncology

Background:

  • Abnormal epigenetic regulation is a key feature of hematologic malignancies.
  • Somatic alterations in key epigenetic proteins are recurrent in myeloid malignancies.
  • Epigenetic dysregulation drives gene expression changes crucial for cancer initiation and progression.

Purpose of the Study:

  • To review major epigenetic regulators.
  • To discuss their aberrant roles in myeloid malignancies.
  • To explore their prognostic significance and therapeutic targeting potential.

Main Methods:

  • Literature review of genomic and epigenomic data.
  • Analysis of recurrent somatic alterations in epigenetic proteins.
  • Synthesis of current understanding of epigenetic mechanisms in myeloid malignancies.

Main Results:

  • Identified key epigenetic regulators involved in DNA methylation, histone modification, and chromatin remodeling.
  • Highlighted the significant role of these proteins in the pathogenesis of myeloid malignancies.
  • Discussed the prognostic implications of aberrant epigenetic profiles.

Conclusions:

  • Targeted epigenetic therapies hold promise for treating myeloid malignancies.
  • A comprehensive understanding of epigenetic mechanisms is essential for effective therapeutic strategies.
  • Further research into epigenetic regulators can uncover new treatment avenues.